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Abstract
Myc is a master transcription factor that has been demonstrated to be required for embryonic stem cell (ESC) pluripotency,
self-renewal, and inhibition of differentiation. Although recent works have identified several Myc-targets in ESCs, the list of
Myc binding sites is largely incomplete due to the low sensitivity and specificity of the antibodies available. To
systematically identify Myc binding sites in mouse ESCs, we used a stringent streptavidin-based genome-wide chromatin
immunoprecipitation (ChIP-Seq) approach with biotin-tagged Myc (Bio-Myc) as well as a ChIP-Seq of the Myc binding
partner Max. This analysis identified 4325 Myc binding sites, of which 2885 were newly identified. The identified sites
overlap with more than 85% of the Max binding sites and are enriched for H3K4me3-positive promoters and active
enhancers. Remarkably, this analysis unveils that Myc/Max regulates chromatin modifiers and transcriptional regulators
involved in stem cell self-renewal linking the Myc-centered network with the Polycomb and the Core networks. These
results provide insights into the contribution of Myc and Max in maintaining stem cell self-renewal and keeping these cells
in an undifferentiated state.
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Introduction
The nuclear factor c-Myc (Myc) is a basic helix-loop-helix
leucine zipper (bHLHZ) transcription factor that binds the
consensus DNA sequence known as the E-Box (CACGTG) when
dimerized with Max [1]. This dimer regulates the transcriptional
activation of target genes. Myc is a master regulatory transcription
factor that has been estimated to bind to over 15% of all
promoters in different cell types, modulating the expression of a
large number of its target genes [2]. Myc is considered a global
gene regulator that acts by recruiting enzymes to the chromatin
that induce covalent modifications in histone tails [3,4]. In
response to environmental stimuli, Myc modulates a large number
of cellular processes, such as proliferation, growth, differentiation,
metabolism, and even apoptosis [3]. Myc also plays a role in ES
cell pluripotency [5–8]. Chromatin immunoprecipitation coupled
with massive parallel sequencing (ChIP-Seq) is a powerful method
for the identification of binding sites of chromatin-associated
proteins, and several experiments have been performed to identify
Myc binding sites [6,9–13]. However, ChIP experiments are
limited by the specificity of the antibody used and the degree of
enrichment achieved in the immunoprecipitation step. The list of
identified genes to which Myc binds is largely incomplete, mainly
because genome-wide analyses of Myc binding sites are hampered
by the quality of the available antibodies. One way to circumvent
this problem is the expression of epitope-tagged proteins.
To generate a more comprehensive map of Myc binding within
the genome in mouse embryonic stem cells (ESCs), we compared
the chromatin immunoprecipitation (ChIP) efficiency of four
affinity tags. We generated ESC clones expressing Myc tagged at
its N-terminus with either a Biotag, a FLAG-HA, or a V5 epitope
and compared the efficiency and selectivity of each in ChIP
experiments under different conditions. A genome-wide analysis
was performed to compare the results of Bio-Myc ChIP-Seq with
previously published ChIP-Seq data obtained with an antibody
recognizing endogenous Myc [9]. We identified a large number of
Myc binding sites that were previously undetected. Because Myc
must form a dimer with Max to bind to an E-Box element, we also
performed ChIP-Seq with Max and found that Myc with Max
share over 85% of their genomic binding sites. The validation of a
group of newly identified genes showed that these genes are
actually bound and regulated by Myc in ESCs.
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Materials and Methods
Cell culture conditions
Mouse embryonic stem cells (ESCs) cells were cultured in
DMEM high glucose medium (Invitrogen) supplemented with
15% FBS (Millipore), 0.1 mM nonessential amino acids (Invitro-
gen), 1 mM sodium pyruvate (Invitrogen), 0.1 mM 2-mercapto-
ethanol, 1500 U of LIF/ml (Millipore), 25 U of penicillin/ml, and
25 mg of streptomycin/ml.
DNA constructs
The cDNA of Myc was cloned into the pEF6/V5-His vector.
Myc was N-terminally tagged by introducing into the KpnI and
SpeI sites of pEF6 vector different tag peptides: Biotag, V5 tag or
FLAG-HA tandem epitopes. Short hairpin RNA (shRNA)
constructs were purchased by Open Biosystems: Myc shRNA 1
(TRCN0000086913), and NMyc shRNA 1 (TRCN0000020694).
Generation of mouse BirA-ES cell lines stably expressing
tagged Myc
To obtain tagged BirA-Myc stable clones, BirA-ESCs were
transfected with linearized Myc constructs using Lipofectamine
2000 Transfection Reagent (Invitrogen) according to the manu-
facturer’s protocol. Transfected cells were cultured for ten days in
growth medium with Blasticidin and drug-resistant clones were
selected for Myc expression.
Nuclear protein extraction and immunoprecipitation
Cells were harvested in 16PBS and resuspended in an isotonic
buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 250 mM Sucrose,
5 mM MgCl2, 5 mM ZnCl2). Then, the cells were resuspended in
an isotonic buffer supplemented with 1% NP40 to isolate the
nuclei. The isolated nuclei were resuspended in digestion buffer
(50 mM Tris-HCl pH 8.0, 100 mM NaCl, 250 mM Sucrose,
0.5 mM MgCl2, 5 mM CaCl2, 5 mM ZnCl2) and treated with
micrococcal nuclease at 30uC for 10 min. The nuclear proteins
were incubated with 3 mg of the specific antibody overnight at
4uC. The immunocomplexes were incubated with protein G-
conjugated magnetic beads (DYNAL, Invitrogen) for 2 h at 4uC.
To immunoprecipitate tagged Myc, the specific anti-tag affinity
beads were used. The samples were washed four times with
digestion buffer supplemented with 0.1% NP-40 at RT. The
proteins were eluted by incubation with 0.4 M NaCl TE buffer for
30 min and analyzed by western blotting.
Chromatin Immunoprecipitation (ChIP) assay
Approximately 26107 cells were cross-linked by addition of
formaldehyde to 1% for 10 min at RT, quenched with 0.125 M
glycine for 5 min at RT, and then washed twice in 16PBS. The
cells were resuspended in Isotonic buffer supplemented with 1%
NP-40 to isolate nuclei. The isolated nuclei were then resuspended
in ChIP Buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM
EDTA and protease inhibitors) supplemented with different
concentration of detergents: 0% SDS, 1% Triton X-100; 0.15%
SDS, 1% Triton X-100; 0.5% SDS, 0.5% Triton X-100; and 1%
SDS, 0% Triton X-100.
Extracts were sonicated using the BioruptorH Twin (Diagenode)
for 2 runs of 10 cycles [30 sec ‘‘ON’’, 30 sec ‘‘OFF’’] at high
power setting. Cell lysate was centrifuged at 12,000 g for 10 min
at 4uC. The supernatant performed in the conditions 3 and 4 was
diluted with ChIP Dilution Buffer (20 mM Tris-HCl pH 8.0,
150 mM NaCl, 2 mM EDTA, 1% Triton) before immunoprecip-
itation step.
Bio-ChIP. Streptavidin beads (DynabeadsH MyOneTM Strep-
tavidin T1) were saturated with PBS/1% BSA at RT for 1 hour,
and then incubated with sample at 4uC for 4 hours on a rotator.
Immunoprecipitated complexes were successively washed with
Washing Buffer I (2% SDS), Washing Buffer II (50 mM HEPES
pH 7.5, 500 mM NaCl, 0.1% Deoxycholate, 1% Triton X-100,
1 mM EDTA), Washing Buffer III (10 mM Tris-Cl pH 8.1,
250 mM LiCl, 0.5% NP-40, 0.5% Deoxycholate, 1 mM EDTA,)
and TE buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA). All
washes were performed at RT for 8 min on a rotator. SDS Elution
Buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS) was
added and incubated at 65uC overnight to reverse crosslink
protein-DNA complexes. After decrosslinking, DNA was purified
using QIAQuick PCR Purification Kit (Qiagen) according to the
manufacturer’s instructions.
V5-ChIP. Anti-V5 tag-magnetic beads (MBL International)
were saturated with PBS/1% BSA at RT for 1 hour, and then
incubated with sample at 4uC for 16 hour on a rotator.
Immunoprecipitate complexes were washed as described previ-
ously [8], eluted with SDS Elution Buffer or with V5 peptide
(Sigma), and then decrosslinked and purified as described above.
FLAG ChIP was performed as V5-ChIP using anti-FLAG M2
magnetic beads (Sigma) for immunoprecipitation and 36FLAG
peptide (Sigma) or SDS Elution Buffer for elution.
For tandem FLAG-HA ChIP, we first immunoprecipitated the
sample by incubating with anti-FLAG M2 magnetic beads (Sigma)
at 4uC for 16 hours on a rotator, then washed and eluted the
immunoprecipitated complexes with 36FLAG peptide (Sigma)
and reincubated the eluate with EZview Red Anti-HA Affinity Gel
(Sigma) at 4uC for 4 hr. After five washes, SDS Elution Buffer or
HA peptide (Sigma) was added, and DNA was decrosslinked and
purified.
For reference sample, BirA-ES cells without tagged protein were
used.
ChIP experiments against endogenous Max, Myc, NMyc and
V5-tag (using antibody) were performed as previously described
[8]. Briefly, extracts were incubated with specific antibodies
overnight and the immunocomplexes were captured using
saturated protein G magnetic beads in gentle rotation for 2 h at
4uC. After 5 washes, the complexes were eluted in SDS Elution
Buffer and DNA was decrosslinked and purified. IgG was used as a
negative control.
RT-qPCR analysis
For the ChIP experiments, immunoprecipitated DNA was
analyzed by quantitative real-time PCR using the SYBR GreenER
kit (Invitrogen). The oligonucleotide sequences are indicated in
Table S1.
RNA was extracted and quantified as previously described [14].
The RNA was analyzed by quantitative real-time PCR using the
Superscript III Platinum One-step qRT-PCR System (Invitrogen).
The oligonucleotide sequences are indicated in Table S2.
Genome-wide bioinformatics analysis
A library was constructed from the eluted DNA using the ChIP-
Seq Sample Prep Kit (Illumina) and sequenced on the Illumina
HiScanSQ Platform. The reads from sequencing were mapped to
the mouse genome (mm9 assembly) using Bowtie version 0.12.7,
reporting only unique hits with up to two mismatches. The
redundant reads were collapsed, and peak calling was performed
using MACS version 1.4.1. For comparative analysis, we
downloaded GEO data for ESC histone modifications
(GSE12241 and GSE11172) and transcription factors
(GSE11431, GSE24843, GSE26833). RNA-Seq data from ESCs
Myc/Max Regulatory Network in Mouse ESCs
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was downloaded from the ENCODE project database [15]. The
LCP-ICP-HCP promoters were defined as in [16], H3K4me3-
only and bivalent promoters were defined as in [17], and active or
poised enhancers were defined as in [18,19]. The ChIP-Seq peak
calling was performed with Macs Software [20] with normaliza-
tion for mock or IgG ChIP at a fixed p-value = 1E-8. Heatmaps
and comparative analysis were performed using custom Perl
scripts. Motif discovery was performed using HOMER [21]. The
ROC curves were generated by calculating the sensitivity and
specificity for the called peaks at different p-values. For cumulative
probability, we selected two groups of gene promoters to be
modeled as background and foreground. For the Max target
promoters, we defined the background as the promoters of the
bottom 50% of the expressed genes that were not bound by Max,
and the foreground was defined as the promoters of the top 50%
of the expressed genes that were bound by Max. For the
H3K4me3 target promoters, we defined the background as the
promoters of the bottom 50% of the expressed H3K4me3-negative
genes, and the foreground was defined as the promoters of the top
50% of the expressed H3K4me3-positive genes. We then
calculated the cumulative probability of each ChIP-Seq raw data
signal for both groups. Gene ontology analyses were performed
using Panther Classification System [22,23].
Results and Discussion
Comparison of different affinity tags for use in chromatin
immunoprecipitation
Myc has been estimated to bind and regulate approximately
15% of all mammalian genes. However, due to the poor specificity
and high background detected with Myc-specific antibodies, only a
fraction of these sites have been previously identified. To obtain a
comprehensive list of Myc binding sites in ESCs, we employed a
tagging approach.
We first compared the efficiency of four affinity tags. We cloned
Myc under the control of a ubiquitous EF1a promoter (pEF6
vector) that remains unmethylated in ES cells. We tagged Myc at
its N-terminus with Biotag, FLAG/HA, or a V5 epitope. The
FLAG and HA epitopes were cloned in tandem to perform a
double consecutive ChIP for better specificity. We generated stable
clones expressing each of the tagged Myc construct in ESCs. The
clones maintained the typical ESC morphology and expressed the
tagged Myc at a level comparable to the endogenous protein
(Figure 1A). To functionally validate the clones, we performed co-
immunoprecipitation experiments to verify that each tagged Myc
formed a complex with the endogenous Max (Figure 1B and
Figure S1).
To compare the binding to the chromatin of the different tagged
Myc proteins, we performed chromatin immunoprecipitation
(ChIP) on the Suz12 and Ezh2 promoters, which were previously
shown to be Myc targets [8]. As negative controls, we used the
H19 and Kdr promoters because these genes were shown not to be
bound by Myc in previous genome-wide studies [9], and their
transcription is nearly undetectable in ESCs by RNA-Seq. We
performed ChIP analyses under different experimental conditions
to establish the best parameters for each tag. The ChIP samples
were analyzed by RT-qPCR, and the results were evaluated as the
fold difference between the ChIP from cells expressing tagged Myc
and the parental mock cells.
The biotin-streptavidin affinity allows the use of high SDS
concentration in ChIP experiments. We performed ChIP analysis
of the Bio-Myc clone using three different concentrations of SDS
(0.15%, 0.5%, and 1%) in lysis buffer (Figure 1A). We observed
good fold enrichment at the Suz12 and Ezh2 promoter regions
Figure 1. Characterization and functional validation of stable
clones expressing tagged Myc. (A) Western blot analysis of the
exogenous tagged Myc expression in the indicated stable clones. Actin
(Actb) was used as a loading control. (B) Immunoprecipitation analysis
of endogenous Max protein in nuclear extracts obtained from the
indicated clones demonstrated that Max is able to co-immunoprecip-
itate with exogenous Myc in each clone analyzed. Purified rabbit IgG
was used as a negative control. (C) RT-PCR analysis of ChIP assays of the
indicated endogenous and tagged proteins. Suz12 and Ezh2 were used
as positive controls, and H19 and Kdr were used as negative controls.
The results are shown as the fold difference.
doi:10.1371/journal.pone.0088933.g001
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with respect to the negative control regions under all SDS
concentrations used. Very low background levels were observed in
the Myc negative control regions as well as in Mock ChIP, most
likely due to the high stringency of the washing buffer used in this
protocol (Figure 1C and Figure S4A, B).
ChIP analysis of the FLAG could only be performed in the
absence of SDS. Under these conditions, we were able to observe a
2- to 3-fold enrichment at the positive regions with respect to the
negative control regions, while the ChIP with higher stringency
lysis buffer (0.15% SDS) did not detect specific binding to the
Suz12 or Ezh2 promoters (Figure S2B). Notably, we observed a
high level of background in the Mock and negative controls in all
FLAG-Myc ChIP experiments, suggesting that some nonspecific
interactions occur in the FLAG immunoprecipitations of the
chromatin (Figure S4A, B). To overcome this problem, we
performed a double consecutive ChIP (TAP-ChIP). We first
immunoprecipitated FLAG-HA-Myc with anti-FLAG M2 beads
and eluted the immunoprecipitated complexes with a 36FLAG
peptide. We subsequently re-immunoprecipitated the eluate using
anti-HA affinity gel. After the second immunoprecipitation, we
eluted the DNA-protein complexes either with SDS buffer or with
HA peptide. Under these conditions we were able to observed a
more evident enrichment at the positive regions with respect to the
negative control regions. We obtained up to fivefold enrichment at
the positive regions in the ChIP experiments with a lower noise-to-
signal level (Figure 1C and Figure S2C).
To immunoprecipitate V5-Myc we used anti-V5 magnetic
beads and performed ChIP analyses under three different
concentrations of SDS (0.15%, 0.5% and 1%). Lysis buffer
containing 0.15% SDS gave better results. In addition, elution
with the V5 peptide led to a higher enrichment in the positive
control regions (Figure 1C and Figure S3A–C), while the ChIP of
V5-Myc using the antibody against V5 conjugated to Protein G
magnetic beads did not show enrichment (Figure S3B). The ChIP
of V5-Myc showed a low level of background, especially when
eluted with the V5 peptide, thus demonstrating its suitability for
this type of application (Figure S4A–C).
In conclusion, ChIP performed by immunopurification using
the V5 tag or double immunopurification using the FLAG-HA
achieved levels of enrichment similar to those obtained with the
anti-Myc antibody. However, the ChIP using the Biotag
demonstrated much better performance than immunopurification
with the specific antibody. Importantly, the Biotag showed the best
signal-to-noise ratio, which is an important parameter to perform
genome-wide ChIP assays.
Genome-wide analysis of Bio-Myc identified a large
number of Myc binding sites that overlap with Max
On the basis of the above results, we performed a genome-wide
analysis using the Bio-Myc ChIP to identify Myc binding sites in
ESCs. To bind DNA at E-Box elements, Myc must form a dimer
with Max. We therefore also performed a ChIP-Seq analysis of
Max and compared the genome-wide results for co-occupancy of
Max with Myc based on the ChIP-Seq of Bio-Myc with the results
obtained with Myc.
We generated heatmaps of the called peaks around the
transcriptional start sites (TSS) 65 kb of all genes rank-ordered
by their mRNA expression levels obtained from the RNA-Seq
analysis [15] (Figure 2A). As expected, the Bio-Myc peaks were
enriched at the TSSs of highly expressed genes. Bio-Myc ChIP-
Seq revealed a significantly larger number of binding sites on gene
promoters with respect to the ChIP-Seq performed with antibodies
recognizing endogenous Myc (Figure 2B). Importantly, the
analysis of Bio-Myc binding sites showed a higher co-occupancy
of Bio-Myc with Max if compared to Myc ChIP-Seq (Figure 2A,
B). Examination of the binding profiles of Bio-Myc, Myc, and Max
at the previously validated E-Boxes of the Suz12 promoter
(2570 bp from TSS) and at the TSS of Ezh2 revealed a well-
defined peak of enrichment for all three genome-wide analyses,
while the analysis showed no binding at the promoters of the
negative controls, the H19 and Kdr genes (Figure 2C).
It has been previously shown that overexpressed Myc could
associate with low-affinity targets at an increased frequency and, at
even higher levels, with other sequences [24] [25]. Motif discovery
analysis of Bio-Myc, Max, and Myc ChIP-Seq analyses showed
that all three ChIP-Seq datasets are enriched for a DNA sequence
containing the perfect E-Box sequence CACGTG with high p-
values: Bio-Myc 1E-205, Myc 1E-255, and Max 1E-588
(Figure 3A). Thus, although Bio-Myc ChIP-Seq identified many
more binding sites, it maintained a similar enrichment of the motif
sequence of the DNA-bound regions, suggesting that all sites
identified by Bio-Myc ChIP–Seq are bona fide Myc binding sites
and were not detected due to overexpression of the tagged protein.
We next divided all of the genes in two categories on the basis of
their promoter binding by Max and calculated the sensitivity and
specificity using Bio-Myc or the antibody anti-Myc at different p-
values overlapping between the two categories. The ROC curve
highlights that Bio-Myc ChIP-Seq is more sensible without loss of
specificity, and it demonstrates the better performance of Bio-Myc
ChIP-Seq in comparison with the ChIP-Seq performed with anti-
Myc antibodies, as shown by the area under curve (AUC)
(Figure 3B). We obtained similar results using promoters marked
by H3K4me3 or by Max binding (Figure 3C). Furthermore, we
generated two datasets of gene promoters. One used as a
background (BG) of Myc binding sites comprised that is formed
by 50% of the less genes with the lowest levels of expression among
those expressed genes that were not bound by Max and, was used
as the background (BG) for the Myc binding sites. The other, used
as a foreground (FG)comprised composed of 50% of the genes
with the highest levels of expression among the genes that were
bound by Max and was used as the foreground (FG) most
expressed genes bound by Max. The cumulative Bio-Myc or Myc
signal distributions are plotted for the background or foreground
regions. Interestingly, the BG curve of for Bio-Myc is more left-
shifted in comparison with the BG curve of for Myc, indicating a
minor density of reads in the background. Consequently, the
distance (d) between the BG and FG curves of Bio-Myc is greater
(Figure 3D). Again, using either H3K4me3 or Max, we found a
similar distribution pattern (Figure 3E). Thus, Bio-Myc ChIP-Seq
identifies a large number of Myc binding sites that could not be
detected using the Myc antibody. This difference can be attributed
to the high affinity of the biotin/streptavidin detection that can be
performed at a very high stringency and to the very low
background that is obtained using this detection system, which
allows the identification of peaks that would not be distinguished
from the background using the Myc- specific antibody.
Biotag-Myc ChIP-Seq shows a high overlap with NMyc on
promoters and enhancers
As shown above, the high level of co-occupancy of Bio-Myc and
Max strongly suggests that the biotin/streptavidin protocol
identifies true Myc binding sites within the genome. Previous
ChIP experiments showed that when coexpressed in the same
cells, Myc and NMyc bind to the same promoters [8]. The analysis
performed using the NMyc ChIP-Seq dataset [9] revealed that
similarly to Bio-Myc, NMyc was able to identify a larger number
of peaks when compared with the sites identified using the anti-
Myc antibodies, most likely due to the major affinity and specificity
Myc/Max Regulatory Network in Mouse ESCs
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of the antibody anti-NMyc. The overlap between the Bio-Myc and
NMyc-bound regions was approximately 70%, demonstrating that
the number of common binding sites between Myc and NMyc is
larger than previously expected (Figure 4A, B). Our results
indicate that the higher number of sites identified by NMyc
compared with those identified using the anti-Myc antibody is not
due to a different binding specificity of the two transcription
factors, but to the higher specificity of the anti-NMyc antibody.
These results suggest that the genome-wide approach may
underestimate the number of total binding sites of a specific
protein, especially in the cases when the antibody used has a low
affinity and/or specificity. In these cases, the use of a tag represents
a better approach to identify bona fide binding sites. In fact, while
we were able to observe the Myc and NMyc binding to all these
promoters by ChIP at each locus by RT-qPCR amplification of
Figure 2. Comparison of Biotag-Myc versus anti-Myc antibody Chip-Seq. (A) Heatmap representation of ChIP-Seq binding for BioMyc, Myc,
and Max around transcriptional start sites (TSSs) 65 kb for all genes rank ordered from the lowest to the most highly expressed according to thee
mRNA expression levels obtained from RNA-Seq analysis. (B) Venn diagram showing the exact number of promoters bound in the indicated ChIP-Seq
analyses. Bio-Myc ChIP-Seq found many more genes bound on TSSs in comparison with the endogenous Myc ChIP-Seq (4325 TSS vs. 1682 TSSs,
respectively), and Bio-Myc ChIP-Seq shows more overlapping genes with Max ChIP-Seq (2306 vs. 1418, respectively). (C) Genomic occupancy profiles
of the indicated Chip-Seq show a well-defined peak of enrichment on the E-Box at the Suz12 promoter (2570 bp from TSS) and the Ezh2 TSS, while
there is no binding at the promoters of the negative control genes (H19 and Kdr).
doi:10.1371/journal.pone.0088933.g002
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the fragment, only the use of Bio-Myc allowed us to identify these
binding sites by genome-wide analysis.
The peaks identified by Bio-Myc and NMyc also show a higher
overlap with open or active promoters marked by trimethylation of
lysine 4 on histone H3 (H3K4me3) and active enhancers marked
by H3K4me1 and H3K27Ac as well as a similar degree of overlap
with Max binding sites (Figure 4C and Figure S4C), suggesting
that Myc and NMyc play similar biological roles in ESCs.
Approximately 50% of newly identified Myc binding sites by Bio-
Myc ChIP-Seq overlap with NMyc targets and the newly
identified Myc bound regions show enrichment in motif sequence
corresponding to the perfect Myc E-Box with a definitely
significant p-value (1E-142) (Figure 4D). Furthermore, gene
ontology analysis showed that the newly identified genes are
Figure 3. Biotag-Myc ChIP-Seq is more sensitive without loss of specificity. (A) Motif discovery analysis showed a significant enrichment for
the E-Box sequence (CACGTG) in all the ChIP-Seq indicated. (B–C) The ROC curve highlights that Bio-Myc ChIP-Seq in comparison with Myc ChIP-Seq
is more sensitive without a loss of specificity at Max or H3K4me3 target genes. The major area under the curve (AUC) for Bio-Myc indicates its better
performance compared with Myc (AUC= 0.80 vs. 0.75 for Max target genes and AUC=0.74 vs. 0.69 for H3K4me3 genes). (D–E) Bio-Myc (left panels) or
endogenous Myc (right panels) ChIP-Seq reads cumulative frequency distributions are plotted for the background and foreground regions calculated
for Max or H3K4me3 binding. A greater distance between the curves in Bio-Myc (d = 0.86 and d=0.78) with respect to the endogenous Myc (d= 0.51
and d=0.45) indicates a greater difference of signal intensity occurring between the background and bound regions.
doi:10.1371/journal.pone.0088933.g003
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Figure 4. Biotag-Myc identifies a large number of Myc binding sites in ESCs. (A) Venn diagram showing the number of gene promoters
bound in the indicated ChIP-Seq analyses and their overlap. (B) Bio-Myc ChIP-Seq was able to identify many more bound regions in comparison with
Myc ChIP-Seq as shown by the number of peaks found at each p-value indicated. (C) The genomic colocalization of Bio-Myc peaks with Max,
H3K4me3-only promoters, and active enhancers at different p-values. Bio-Myc ChIP-Seq always reveals a major number of peaks overlapping with the
indicated genomic features and shows a similar distribution to the NMyc dataset. (D) About 50% of the newly identified Myc-bound promoters show
overlap with NMyc targets and an enrichment in the motif sequence corresponding to the perfect Myc E-Box (p-value 1E-142). (E–F) Gene ontology
analysis reveals that the newly identified Myc target genes are enriched for genes associated with the cell cycle and cell metabolism as well as genes
with molecular functions involved in the metabolism of nucleic acid and chromatin structure.
doi:10.1371/journal.pone.0088933.g004
Myc/Max Regulatory Network in Mouse ESCs
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involved in cell cycle progression, cell metabolism, and molecular
functions involved in the metabolism of nucleic acid, correspond-
ing to the gene categories usually associated with Myc proteins
(Figure 4E, F).
The newly identified genes by Bio-Myc ChIP-Seq are
actually bound by Myc in ES Cells
To further investigate the genes identified by Bio-Myc ChIP-
Seq analysis that were not identified using the anti-Myc antibody,
we analyzed the effective role of Myc in the regulation of these
genes. We first compared the binding profiles of Bio-Myc, Myc,
Max, and NMyc on two groups of genes. The first group is
composed of the genes that are also bound by NMyc (Figure 5A),
while the second group is composed of the genes that are bound
only by Bio-Myc, but not by NMyc (Figure 5B). The genomic
occupancy profiles revealed a very similar binding pattern of Bio-
Myc and Max to the promoters of the second group of genes, and
they showed an analogous binding pattern of NMyc for the first
group genes. Interestingly, in the Myc ChIP-Seq of the first group
of genes (Figure 5A) as well as in the NMyc ChIP-Seq of the
second group genes (Figure 5B), several sporadic reads corre-
sponding to the peak of Bio-Myc on gene promoters are evident.
Although these signals are below the general background level,
these reads may indicate the detection of Myc binding sites by the
anti-Myc antibody. However, the sensitivity of the ChIP-Seq
technique does allow the identification of these low signals as true
peaks. To verify Myc binding at these genes, we performed ChIP
followed by RT-qPCR analysis to reveal the binding of
endogenous Myc. We noted a significant enrichment of Myc by
ChIP at all regions that were identified by Bio-Myc ChIP-Seq in
comparison with IgG and the negative controls (H19 and Kdr
gene) (Figure 5C). In addition, ChIP analysis also revealed NMyc
and Max binding to the chromatin of these genes (Figure 5D).
We next verified whether these newly identified genes bound by
Myc are actually regulated by Myc. To this end, we silenced the
Myc protein in ES cells (Figure 6A and B). In agreement with
previous data [8], knockdown of Myc resulted in the downregu-
lation of the expression of Suz12 and Ezh2, which were used as
controls (Figure 6C). Together with Suz12 and Ezh2, all the new
genes identified by Bio-Myc were also down regulated, including
those that were not identified by NMyc (Figure 6C), demonstrating
that Myc positively regulate these genes. Because these genes are
involved in the cell cycle, cell metabolism, and in the maintenance
of the chromatin signature in ES cells, the knowledge of their
Figure 5. The newly identified genes by Biotag-Myc ChIP-Seq are bound by endogenous Myc in ES cells. (A–B) Representative genomic
occupancy profiles of genes identified by Bio-Myc ChIP-Seq but not by endogenous Myc ChIP-Seq. The genes were divided in two groups. The first
group is composed of the genes that are also bound by NMyc (A) while the second group is composed of the genes that are bound only by Bio-Myc
(B). (C) RT-qPCR analysis of endogenous Myc ChIP samples at the promoters of the indicated genes. The Suz12 and Ezh2 genes were used as positive
controls, and the H19 and Kdr genes were used as negative controls. The results are shown as the percentage (1/100) of the input. (D) RT-qPCR
analysis of endogenous NMyc and Max ChIP reveals their binding to the promoters of the second group of genes. The Suz12 and Ezh2 genes were
used as positive controls, the H19 and Kdr genes were used as negative controls. The results are shown as the percentage (1/100) of the input.
doi:10.1371/journal.pone.0088933.g005
Figure 6. The genes identified by Biotag-Myc are regulated by Myc in ES cells. (A) RT-PCR analysis of Myc and NMyc expression in double
knockdown ES cells. The results are shown as a fold difference. (B) Western blot analysis of Myc protein level in double-knockdown ES cells. b-actin
was used as a loading control. (C) RT-PCR analysis of the indicated transcripts upon a double knockdown (dKD) of Myc proteins. The Suz12 and Ezh2
genes were used as positive controls, and the H19 and Kdr genes were used as negative controls. The results are shown as the fold difference.
doi:10.1371/journal.pone.0088933.g006
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regulation by Myc could allow a better understanding of the
biological role of Myc in ES cells.
Using biotin-tagged Myc, we identified a more comprehensive
genome-wide analysis of the Myc binding sites in ESCs than those
obtained with Myc specific-antibodies. This approach could be
employed in general for the identification of the binding profile of
any chromatin-associated protein. The use of the Biotag also
demonstrated the advantage of a better comparison between the
different factors and the possibility to analyze the binding activities
of mutants or alternative splice variants, which could not be
distinguished by specific antibodies.
To bind to the E-Box element and regulate its target genes, Myc
must form a dimer with its partner Max. Importantly, to maintain
ESC pluripotency, Myc requires the expression of Max [26]. From
the data obtained, we generated a Myc/Max-dependent regula-
tory network that integrates previously identified Myc-genes with
the genes identified in this study (Figure 7). The model includes a
subset of representative Myc/Max co-bound targets involved in
transcriptional activation, cell cycle progression, ESC self-renewal,
and developmental processes. In line with the view of Myc as a
general transcriptional activator, in addition to the previously
identified Myc-target genes Gcn5, Myst2, and P400, we found
other histone modifying factors that positively regulate transcrip-
tion, such as Setd3, Mll1, Mll3, and Wdr5. Interestingly, our study
also identified other categories of ES cell regulators.
Conclusions
Previous genome-wide analysis of the Myc binding sites in ESCs
suggested that the Myc-centered regulatory network is largely
independent from the networks controlled by the core pluripotent
factors and from Polycomb because each of these networks (or
modules) regulates largely independent sets of target genes with
distinct roles in maintaining ES cell self-renewal, undifferentiation,
and proliferation [10]. Our genome-wide study also identified as
Myc-targets the ESC-specific genes Stat3, Sox2, and Zfp42 (Rex1),
which are factors involved in maintaining ESC pluripotency. This
analysis also identified additional components of the Polycomb
PRC1 and PRC2 complexes, which maintain the transcription of
developmental genes in ES cells. Thus, our study suggests that the
Figure 7. Myc/Max transcriptional targets in ESCs. Schematic representation of Myc/Max bound genes in ES cells (the genes identified in this
work are indicated in red) and their molecular and biological functions.
doi:10.1371/journal.pone.0088933.g007
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Myc-centered regulatory network, the core, and the Polycomb
modules are more interconnected than previously thought,
providing an explanation for the observation that Myc plays an
essential role in maintaining ESC self-renewal and the undiffer-
entiated state [6] [8].
Supporting Information
Figure S1 Characterization and Functional Validation
of Tagged c-Myc Stable Clones. (A) Western blot analysis of
the exogenous tagged c-myc expression in the indicated stable
clones. The level of expression was determined by using the
antibody 9e10. Beta-actin was used as a loading control. (B–D)
Western blot analysis of affinity tags expression in the indicated
stable clones. Beta-actin was used as a loading control. (E)
Immunoprecipitation analysis of endogenous Max protein in
nuclear extracts obtained from the indicated clones demonstrated
that Max is able to coimmunoprecipitate with exogenous Myc in
each clone analysed. Purified rabbit IgG were used as negative
control. (F) Immunoprecipitation analysis of exogenous Myc using
the corresponding affinity beads showed its interaction with
endogenous Max in each clone analysed.
(TIF)
Figure S2 Analysis of Biotag and Flag-HA ChIP Assays.
(A) RT-PCR analysis of Bio-Myc_5B ChIP performed under three
different concentrations of SDS (0.15%, 0.5% and 1%) in lysis
buffer. The Suz12 and Ezh2 genes were used as positive controls,
the H19 and Kdr genes were used as negative controls. The results
are shown as a fold difference. (B) RT-PCR analysis of Flag ChIP
performed in two different Flag-HA-Myc stable clones. Two
different concentrations of SDS (0.15%, 0%) in lysis buffer, and
two different types of elution for each condition were used as
indicated. The Suz12 and Ezh2 genes were used as positive
controls, the H19 and Kdr genes were used as negative controls.
The results are shown as a fold difference. (C) RT-PCR analysis of
TAP ChIP performed in two different Flag-HA-Myc stable clones.
Flag-HA-Myc was first immunoprecipitated with anti-Flag M2
beads and then it was reimmunoprecipitated using anti-HA
affinity gel. The immunoprecipitation was performed in lysis
buffer containing 0% of SDS. Two different types of elution were
used as indicated. The Suz12 and Ezh2 genes were used as positive
controls, the H19 and Kdr genes were used as negative controls.
The results are shown as a fold difference.
(TIF)
Figure S3 Analysis of V5 ChIP Assay. (A) RT-PCR analysis
of V5-Myc_3A ChIP performed under three different concentra-
tions of SDS (0.15%, 0.5% and 1%) in lysis buffer, and two
different types of elution for each condition. The Suz12 and Ezh2
genes were used as positive controls, the H19 and Kdr genes were
used as negative controls. The results are shown as a fold
difference. (B) RT-PCR analysis of V5 ChIP performed in two
different V5-Myc stable clones under the indicated concentration
of SDS in lysis buffer. V5-Myc was immunoprecipitated either
with V5 magnetic beads or with anti-V5 antibody and two
different types of elution for each condition were performed. The
Suz12 and Ezh2 genes were used as positive controls, the H19 and
Kdr genes were used as negative controls. The results are shown as
a fold difference. (C) RT-PCR analysis of V5 ChIP performed in
two different V5-Myc stable clones under the indicated concen-
tration of SDS in lysis buffer. V5-Myc was immunoprecipitated
with V5 magnetic beads and two different types of elution for each
condition were performed. The Suz12 and Ezh2 genes were used
as positive controls, the H19 and Kdr genes were used as negative
controls. The results are shown as a fold difference.
(TIF)
Figure S4 Comparison of Different Types of Affinity
Tags for Use in Chromatin Immunoprecipitation. (A)
RT-qPCR analysis of ChIP assays of the indicated endogenous
and tagged proteins under the conditions indicated. The Suz12
and Ezh2 genes were used as positive controls, the H19 and Kdr
genes were used as negative controls. The results are shown as
percentage (1/100) of input. (B) Backround average level of the
indicated ChIP assays shown as percentage (1/100) of input.
Background was calculated as the average of the values obtained
from mock or IgG ChIP on two positive (Suz12, Ezh2) and two
negative (H19, Kdr) regions plus the values of the indicated ChIP
on the two negative regions (H19, Kdr). (C) Overlap between Myc
binding regions and promoters and enhancers with the indicated
features.
(TIF)
Figure S5 Analysis of the Myc, Core and Polycomb
modules target genes in ESC. (A) Venn diagram showing the
exact number of promoters bound in the indicated ChIP-Seq
analyses. Since Oct3/4 and Polycomb could bind not exactly on
TSS, the analysis was performed keeping the genes bound in a
larger region near TSS (between -3kb and +2kb). (B) Clustering
analysis of the global Pearson correlation of the indicated ChIP-
Seq showing the independence of the three modules in ESC.
(TIF)
Table S1 ChiP primers.
(DOCX)
Table S2 RT-PCR primers.
(DOCX)
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